Up-to-date access to technology licensing opportunities worldwide.
Displaying 1..8 of 8 -
10
20
50
100
per page
Order by
number of views
addition date
development phase
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success.
More
Lactase Enzyme for infant colic induced by Transient Lactose Deficiency in infants
More
High concentrated liquid Omega 3 for infants
More
Purified Microfine Red Sanders Wood Powder having High Drug and Colour Values: Use in Skin Therapeutics
More
Recovery of Hydrophobic Peptides: Production of Highly Pure Flax Oil Cyclolinopeptide
More
Methods for Producing Secondary Metabolites: Unnatural Production of Natural Products
More
Displaying 1..8 of 8 -
10
20
50
100
per page
Order by
number of views
addition date
development phase
Feb 2011 - 7 pages - $500
Nov 2010 - 411 pages - $600
Nov 2010 - 379 pages - $600
Nov 2010 - 205 pages - $600
Nov 2010 - 63 pages - $600
Nov 2010 - 52 pages - $600
Nov 2010 - 55 pages - $600
Nov 2010 - 106 pages - $600
Nov 2010 - 75 pages - $600
Nov 2010 - 51 pages - $600